PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels
PetMed Express, Inc. PETS
$1.25
▲ +2.46%
(+$0.03)
⚡ High Volume
📅 Earnings This Week
Open
$1.23
Prev Close
$1.22
Day Range
$1.21 – $1.29
52W Range
$1.15 – $4.10
Market Cap
$27.10M
Beta
0.83
EPS (TTM)
$-1.39
📋 Company Profile
| Industry | Retail |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-04-06 |
| Shares Out. | 21,680,000 |
| Website | 1800petmeds.com/ ↗ |
| Phone | 15614264444 |
| Employees | 189 |
| Revenue | $41.0M |
| Gross Profit | $11.3M |
| Net Income | -$6.1M |
| Free Cash Flow | -$27.8M |
| Total Assets | $63.8M |
| Total Liabilities | $40.8M |
| Equity | $23.0M |
About PetMed Express, Inc.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
PetMed Express, Inc. is a publicly traded company under the ticker symbol PETS on the NASDAQ NMS - GLOBAL MARKET, operating in the Retail industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-11-01)